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INTRODUCTION
Over the years, developments in the management of portal hy-
pertension and variceal bleeding have led to a significant re-
duction in mortality.1 Pharmacologic and endoscopic thera-
pies remain the first-line treatment for prevention and treatment 
of variceal bleeding. In cases of first-line treatment failure, sec-
ondary options may be considered: surgical shunt creation, 
liver transplantation, and percutaneous treatments. 
Transjugular intrahepatic portosystemic shunt (TIPS) is a 
well-described and widely performed technique to create a 
shunt between systemic and portal circulations, generally he-
patic vein and portal vein, thereby bypassing the congested 
hepatic system. Unfortunately, portal vein thrombosis (PVT) 
occurs frequently in cirrhosis patients,2 and have been reported 
to lower TIPS success rates to 40–75%.3 While surgical shunt is 
a viable option, patients who do not meet surgical indications 
are left with very limited options. In this case report, we de-
scribe an endovascular mesocaval shunt creation with trans-
splenic approach to successfully manage variceal bleeding in 
a patient with total portal vein occlusion.
CASE REPORT
A 16-year-old female patient with portal hypertension and 
chronic portal vein occlusion was admitted for persistent me-
lena and severe anemia. Patient history included duodenum-
preserving resection of pancreatic head and Roux-en-Y pancre-
aticojejunostomy due to choledochal cyst at early childhood. 
Capsule endoscopy confirmed active bleeding with a large 
amount of blood clot at proximal jejunum (Fig. 1B). However, 
contrast-enhanced CT demonstrated total intra- and extrahe-
patic portal vein obliteration with intrahepatic collaterals and 
splenomegaly, rendering TIPS unfeasible (Fig. 1A). Alternatively, 
mesocaval shunt formation was decided under informed con-
sent. Under US-guidance, a direct puncture of the splenic vein 
was done using a 21-G Chiba needle (Cook Medical, Blooming-
ton, IN, USA) and a 7-Fr Flexor Check-Flo Ansel modification 
sheath (Cook Medical). Angiography showed total obliteration 
of superior mesenteric vein (SMV) with cavernous transfor-
mation and collateral vessels (Fig. 1C). An 11-mm Arrow bal-
loon catheter (Teleflex, Dublin, Ireland) was placed at the SMV-
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splenic vein confluence as a fluoroscopic target. A 16-G Colapinto 
needle and a 9-Fr Teflon sheath (Transjugular Liver Access Set, 
Cook) were coaxially loaded over a guidewire via US-guided 
puncture of right internal jugular vein. Sheath tip was placed at 
the inferior vena cava (IVC), with a 0.035-inch guidewire placed 
at nearby common hepatic artery, due to concerns for vascu-
lar injury. Under fluoroscopic guidance, the Colapinto needle 
was advanced towards the target balloon, traversing the cau-
date lobe (Fig. 2A and D). After successful puncture of SMV, 
predilation of the extrahepatic tract was performed with 5-mm 
Mustang balloon catheter (Boston Scientific, Marlborough, MA, 
USA). An 8-mm×7-cm stent-graft (S&G Biotech, Seongnam, 
Korea) was placed, followed by stent dilatation using an 8-mm 
FoxCross balloon catheter (Abbott Laboratories, Abbott Park, 
IL, USA). Another 7-mm×23-mm Palmas Blue stent (Cordis, 
Miami, FL, USA) was placed at splenic vein to prevent shunt 
wasting. Final angiography revealed patent flow between the 
SMV to IVC with an inverted “Y”-stent configuration (Fig. 2B, C, 
and D) with decreased gastric varices. Portal vein pressure de-
creased immediately from 26-mmHg to 6-mmHg. Transsplenic 
tract embolization was done using histoacryl glue. No imme-
diate complications occurred. At 9 month follow-up, mild gas-
trointestinal (GI) bleeding symptom recurred despite the dis-
appearance of esophageal varices at endoscopy. Mild stenosis 
of the proximal stent was observed and treated with balloon 
dilatation. Shunt patency was maintained up to 24-month fol-
low-up, with intermittent balloon dilatation of proximal stent 
stenosis.
       
DISCUSSION
Initially described by Nyman, et al.,4 a total of eight cases of 
mesocaval shunt creation in the presence of chronic portal oc-
clusion4-8 have been reported in English publications (Table 1). 
While mesocaval shunt creation may be offered to patients 
who are not surgical and/or TIPS candidates, certain anatomic 
requirements must be met. Preoperative contrast-enhanced CT 
should be performed to evaluate anatomic feasibilities, since 
potential complications may vary depending on the patient’s 
anatomy.9 Injuries may occur at adjacent vasculatures, pan-
creas, duodenum, and any other structures. One case reported 
mesocaval shunt creation through the pancreatic uncinate pro-
cess without complications.5 However, transpancreatic ap-
proach involves theoretical complications of pancreas bisec-
tion leading to pancreatic hemorrhage or inflammation7 and 
should be avoided if possible. 
While most of the reported cases created entirely extrahepat-
ic mesocaval shunts, we created a partially intrahepatic shunt 
by traversing the caudate lobe. A potential advantage for par-
tially intrahepatic shunt is the prevention of shunt migration. 
Because a completely extrahepatic shunt lacks suitable anchor-
ing structures, acute or delayed shunt migration has been sug-
gested as a potential complication.5 It should be noted that, in 
the presented case, mild stenosis without thrombotic occlu-
sion of the stent graft required repeated balloon dilatation. 
Whether the surrounding hepatic parenchyme contributed to 
intrahepatic stent graft stenosis is unclear. 
To our best knowledge, this is only the second case of endo-
vascular mesocaval shunt creation, with a unique use of trans-
splenic approach. Transcolonic,4 transgastric,8 or transabdomi-
nal6,7,9 routes have been utilized, but there are concerns for 
increased risks of peritonitis, sepsis and hemorrhage.5,6,8,9 Alter-
natively, a direct puncture of the splenic vein under US-guid-
ance was adopted. Although not widely advocated, transsplen-
ic approach has been shown to be safe and feasible for portal 
vein intervention with preventable complications.10-13 Moreover, 
transsplenic endovascular process can bypass direct puncture 
of the abdominal wall, intestines, and major vessels with a single 
needle, reducing the risk of infection. In addition, the risk of 
hemorrhage may be reduced since only one wall of the SMV 
is punctured.5 
Fig. 1. Portal phase of preoperative contrast-enhanced CT image (A) shows total occlusion of portal vein due to extensive thrombosis (arrow) and 
cavernous malformation of intrahepatic portal veins with splenomegaly. Capsule endoscopy (B) revealed active bleeding and a large amount of blood 
clots at proximal jejunum. SMV angiography (C) shows cavernous transformation of intrahepatic portal vein (asterisk), and collateral vessels are 
seen. Total obliteration of SMV (open arrow) is noted. SMV, superior mesenteric vein.
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Despite the lack of long-term mortality analysis, mesocaval 
shunt offers an effective alternative treatment in patients with 
limited options due to PVT. Previous reports indicate that pa-
tients did not have recurrent thrombosis or variceal bleeding 
for as long as 18 months. Although our patient developed re-
current GI bleeding at 9 months, mesocaval shunt remained 
patent up to 24 months, which is the longest follow-up period 
up to date. Therefore, mesocaval shunt offers an alternative 
treatment in cases where TIPS cannot be applied. To determine 
its utility in clinical settings, further research on long-term du-
rability of mesocaval shunt is warranted. 
In conclusion, intrahepatic and extrahepatic PVT or occlu-
sion poses a great challenge in creating percutaneous porto-
systemic shunts in portal hypertension patients. We present a 
successful fluoroscopy-guided, endovascular mesocaval shunt 
creation technique that can relieve portal hypertension and 
variceal bleeding in patients with total portal vein occlusion. 
ORCID
Ja Kyung Yoon https://orcid.org/0000-0002-3783-977X
Man-Deuk Kim https://orcid.org/0000-0002-3575-5847
Fig. 2. Mesocaval shunt creation. (A) A 16-G Colapinto needle and a 9-Fr Teflon sheath were coaxially loaded over a guidewire via US-guided punc-
ture of right IJV. Via US-guided puncture of the splenic vein, an 11-mm balloon catheter was placed at the SMV-splenic vein confluence. The inflated 
balloon was used as a fluoroscopic target. A 0.035-inch guidewire (black arrow) was placed in the dilated hepatic artery to avoid puncture of the tar-
get. (B) Final angiography shows patent mesocaval shunt between IVC and SMV. (C) CT-rendered three-dimensional image reveals patent stent graft 
(white arrow) with partial intrahepatic portion at the proximal end. Additional stent at distal splenic vein (arrowhead) to prevent shunt wasting result-
ed in an inverted “Y” configuration of stents. (D) Simplified diagram of transsplenic mesocaval shunt technique. Linear arrow represents the direction 
of puncture (splenic vein stent is not shown). IJV, internal jugular vein; SMV, superior mesenteric vein; IVC, inferior vena cava.
A
C
B
D
165
Ja Kyung Yoon, et al.
https://doi.org/10.3349/ymj.2018.59.1.162
REFERENCES
1. Garcia-Tsao G, Sanyal AJ, Grace ND, Carey W; Practice Guidelines 
Committee of the American Association for the Study of Liver 
Diseases; Practice Parameters Committee of the American Col-
lege of Gastroenterology. Prevention and management of gastro-
esophageal varices and variceal hemorrhage in cirrhosis. Hepa-
tology 2007;46:922-38.
2. Stine JG, Shah NL, Argo CK, Pelletier SJ, Caldwell SH, Northup PG. 
Increased risk of portal vein thrombosis in patients with cirrhosis 
due to nonalcoholic steatohepatitis. Liver Transpl 2015;21:1016-21.
3. Wils A, van der Linden E, van Hoek B, Pattynama PM. Transjugu-
lar intrahepatic portosystemic shunt in patients with chronic por-
tal vein occlusion and cavernous transformation. J Clin Gastroen-
terol 2009;43:982-4.
4. Nyman UR, Semba CP, Chang H, Hoffman C, Dake MD. Percuta-
neous creation of a mesocaval shunt. J Vasc Interv Radiol 1996;7: 
769-73.
5. Hong R, Dhanani RS, Louie JD, Sze DY. Intravascular ultrasound-
guided mesocaval shunt creation in patients with portal or mes-
enteric venous occlusion. J Vasc Interv Radiol 2012;23:136-41.
6. Burke C, Taylor AG, Ring EJ, Kerlan RK Jr. Creation of a percutane-
ous mesocaval shunt to control variceal bleeding in a child. Pedi-
atr Radiol 2013;43:1218-20.
7. Bercu ZL, Sheth SB, Noor A, Lookstein RA, Fischman AM, Nowa-
kowski FS, et al. Percutaneous mesocaval shunt creation in a pa-
tient with chronic portal and superior mesenteric vein thrombo-
sis. Cardiovasc Intervent Radiol 2015;38:1316-9.
8. Moriarty JM, Kokabi N, Kee ST. Transvenous creation of a meso-
caval shunt: report of use in the management of extrahepatic portal 
vein occlusion. J Vasc Interv Radiol 2012;23:565-7.
9. Davis J, Chun AK, Borum ML. Could there be light at the end of the 
tunnel? Mesocaval shunting for refractory esophageal varices in 
patients with contraindications to transjugular intrahepatic por-
tosystemic shunt. World J Hepatol 2016;8:790-5.
Table 1. Summary of Previous Case Reports of Mesocaval Shunt Creation
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37/M
Idiopathic chronic PVT
Recurrent massive variceal bleeding
Failed prior surgical shunt attempts
CT and fluoroscopy Transcolonic
Thrombosis (+)*
Recurrent variceal bleeding (-)
Follow-up period: 14 months
Nyman, et al.4
57/M
Metastatic CRC with multiple metastastectomies
Extrahepatic PVT
Failed TIPS attempt
CT and fluoroscopy Transgastric
Thrombosis (+)† 
Recurrent variceal bleeding (+)†
Follow-up period: 3 months
Moriarty, et al.8
16/F
Chronic PVT
Recurrent GI bleeding
Failed previous splenorenal shunt
Fluoroscopy and 
  IVUS
Endovascular
Side-firing IVUS 
  probe
Thrombosis (-)
Recurrent variceal bleeding (-)
Follow-up period: 11 months
Hong, et al.5
60/F
HCC with PV obliteration due to tumor thrombi
Failed variceal banding
Fluoroscopy and 
  IVUS
Endovascular
Side-firing IVUS 
  probe‡
Thrombosis (-)
Recurrent variceal bleeding (-) 
Follow-up period: 10 months
Hong, et al.5
55/M
Pancreatic teratoma S/P Whipple OP
Segmental occlusion of SMV
Failed endoscopic clipping
Fluoroscopy and 
  IVUS
Endovascular
Side-firing IVUS 
  probe
Thrombosis (-)
Recurrent variceal bleeding (-)
Follow-up period: 3 months
Hong, et al.5
13/M
Extrahepatic portal vein occlusion
Failed surgical shunt attempt
Retroperitoneal rhabdomyosarcoma 
  S/P surgical resection and RT
CT Transabdominal
Thrombosis (-)
Recurrent variceal bleeding (-)
Follow-up period: 18 months
Burke, et al.6
58/F
C-viral cirrhosis with recurrent ascites
Portal vein and SMV thrombosis
Failed previous splenorenal shunt and TIPS attempt
Fluoroscopy Transabdominal
Thrombosis (-)
Recurrent variceal bleeding (-)
Follow-up period: 3 months
Bercu, et al.7
N/A
Cirrhosis
PVT (+)
CT and fluoroscopy Transabdominal N/A Davis, et al.9
16/F
Chronic PVT
Choledochal cyst S/P surgical resection
Fluroscopy Transsplenic
Thrombosis (-)
Recurrent variceal bleeding (+)§
Follow-up period: 24 months
Present case
N/A, not available; PVT, portal vein thrombosis; CRC, colorectal cancer; TIPS, transjugular intrahepatic portosystemic shunt; GI, gastrointestinal; HCC, hepatocel-
lular carcinoma; PV, portal vein; OP, operation; SMV, superior mesenteric vein; RT, radiation therapy; S/P, status post; POD, post-operative day; IVUS, intravascular 
ultrasound. 
*Thrombosis occurred at POD #1, which was fully recanalized by balloon embolectomy. 12-month follow-up angiography revealed thrombotic occlusion of the 
second mesocaval shunt, but patient did not have recurrent symptoms and no further intervention was performed, †Angiography at 24-hours was performed due 
to recurrent GI bleeding revealing total thrombotic occlusion of the mesocaval shunt. Failure of recanalization led to a second mesocaval shunt creation, ‡Unci-
nate process of pancreas was traversed without significant complications, §Minor lower GI bleeding recurred at 9 months follow-up, but shunt patency was con-
firmed for 24 months. 
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